Compare DFLI & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFLI | ELUT |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 48.3M |
| IPO Year | N/A | 2020 |
| Metric | DFLI | ELUT |
|---|---|---|
| Price | $1.92 | $1.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.25 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 362.4K | 62.8K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $51.17 | $10.83 |
| P/E Ratio | ★ N/A | $1.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.15 | $0.50 |
| 52 Week High | $5.15 | $2.60 |
| Indicator | DFLI | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 39.03 |
| Support Level | $1.56 | $1.00 |
| Resistance Level | $2.24 | $1.18 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 5.37 | 4.87 |
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.